Stella, Salvatore Massimo
Saponara, Annarita
Gualtierotti, Roberta https://orcid.org/0000-0001-6465-7624
Vita, Fabio
Miccoli, Mario
Becciolini, Marco
Galletti, Stefano
Cotellessa, Filippo
Trompetto, Carlo
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente)
Article History
Received: 29 September 2024
Accepted: 9 September 2025
First Online: 23 September 2025
Declarations
:
: Roberta Gualtierotti is on the advisory boards of Bayer, Biomarin, Roche, Sanofi, SOBI, and Novo Nordisk, and has participated in speaker bureau/educational meetings for Biomarin, Pfizer, SOBI, Takeda, and Novo Nordisk. Roberta Gualtierotti is an Editorial Board member for Pain and Therapy. Roberta Gualtierotti was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Salvatore Massimo Stella, Annarita Saponara, Fabio Vita, Marco Becciolini, Mario Miccoli, Galletti Stefano, Cotellessa Filippo, and Trompetto Carlo have nothing to disclose.
: The present study was approved by the Università degli Studi di Genova Comitato Etico per la Ricerca di Ateneo (CERA), Ethics Committee approval n° 2025/51. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All participants provided written informed consent to participate in the study and for the publication of anonymous imaging.